Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 8.


Giannoudis, Athina, Malki, Mohammed I, Mohammed, Hisham, Rudraraju, Bharath, Menon, Suraj, Ali, Simak, Carroll, Jason S and Palmieri, Carlo
(2020) Abstract P6-04-18: The regulatory role of activating transcription factor-2 (ATF2) in modulating tamoxifen resistance in estrogen-receptor positive breast cancer. In: Abstracts: 2019 San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas.


Szijgyarto, Zsolt, Flach, Koen D, Opdam, Mark, Palmieri, Carlo, Linn, Sabine C, Wesseling, Jelle, Ali, Simak, Bliss, Judith M, Cheang, Maggie Chon U, Zwart, Wilbert
et al (show 1 more authors) (2019) Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES. BREAST CANCER RESEARCH AND TREATMENT, 175 (1). 149 - 163.


Ruenraroengsak, Pakatip, Kiryushko, Darya, Theodorou, Ioannis G, Klosowski, Michal M, Taylor, Erik R, Niriella, Thisa, Palmieri, Carlo, Yague, Ernesto, Ryan, Mary P, Coombes, R Charles
et al (show 2 more authors) (2019) Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cells. NANOSCALE, 11 (27). 12858 - 12870.


Palmieri, Carlo, Szydlo, Richard, Miller, Marie, Barker, Laura, Patel, Neva H, Sasano, Hironobu, Barwick, Tara, Tam, Henry, Hadjiminas, Dimitri, Lee, Jasmin
et al (show 4 more authors) (2017) IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer. BREAST CANCER RESEARCH AND TREATMENT, 166 (2). 527 - 539.


Palmieri, Carlo, Stein, Rob C, Liu, Xinxue, Hudson, Emma, Nicholas, Hanna, Sasano, Hironobu, Guestini, Fouzia, Holcombe, Chris, Barrett, Sophie, Kenny, Laura
et al (show 6 more authors) (2017) IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 165 (2). 343 - 353.


Ricciardelli, Carmela, Bianco-Miotto, Tina, Jindal, Shalini, Butler, Lisa M, Leung, Samuel, McNeil, Catriona M, O'Toole, Sandra A, Ebrahimie, Esmaeil, Millar, Ewan KA, Sakko, Andrew J
et al (show 8 more authors) (2018) The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome. CLINICAL CANCER RESEARCH, 24 (10). 2328 - 2341.


Olsson-Brown, Anna, Piskilidis, Pavlos, O'Hagan, Julie, Thorp, Nicky, Robson, Peter, Innes, Helen, Wong, Helen, Cicconi, Silvia, Jackson, Richard, Kiernan, Tamara
et al (show 3 more authors) (2019) The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool. BREAST, 44. 94 - 100.


Giannoudis, Athina ORCID: 0000-0002-7200-1497, Clarke, Kim, Zakaria, Rasheed ORCID: 0000-0001-6826-2662, Vareslija, Damir, Farahani, Mosavar, Rainbow, Lucille ORCID: 0000-0003-0447-6885, Platt-Higgins, Angela, Ruthven, Stuart, Brougham, Katherine A, Rudland, Philip S ORCID: 0000-0002-7491-0846
et al (show 4 more authors) (2019) A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival. SCIENTIFIC REPORTS, 9.

This list was generated on Fri May 15 19:56:25 2020 BST.